- Home
- KRO vs OPK Comparison
KRO vs OPK Comparison
Compare KRO & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRO | OPK |
|---|---|---|
| Founded | 1916 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2004 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KRO | OPK |
|---|---|---|
| Price | $8.36 | $1.60 |
| Analyst Decision | Strong Sell | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $6.00 | $1.60 |
| AVG Volume (30 Days) | 332.8K | ★ 2.6M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $1,859,400,000.00 | $606,879,000.00 |
| Revenue This Year | $6.75 | N/A |
| Revenue Next Year | $8.36 | $4.24 |
| P/E Ratio | $90.89 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.08 | $0.98 |
| 52 Week High | $9.17 | $1.73 |
Technical Indicators
Market Signals| Indicator | KRO | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 57.26 |
| Support Level | $5.97 | $1.12 |
| Resistance Level | $9.03 | $1.58 |
| Average True Range (ATR) | 0.38 | 0.07 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 23.08 | 41.82 |
Price Performance
Historical ComparisonAbout KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The maximum of revenue comes from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.